Primary Care Providers

Articles with relevant information for Primary Care Providers (PCP).
08May

Provider Alert! Monovalent Moderna and Pfizer-BioNTech COVID-19 Vaccines Removed From Formulary on April 21, 2023

Date: May 8, 2023 Attention: All Providers Effective Date: April 21, 2023 Call to action: Texas Children Health Plan (TCHP) would like to inform providers that effective April 21, 2023, the U.S. Food and Drug Administration (FDA) amended the emergency use authorizations of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines. This is to simplify the vaccination schedule for most individual vaccines, and monovalent are no longer authorized for use in the United States. This announcement includes authorizing the current bivalent vaccines (original and...

By Facilities, OB/GYNs, Office Managers, Primary Care Providers, Provider Alert, Specialists, , , , , 0 CommentsRead more...
Provider Alert!
04May

Provider Alert! Quantity Limit Change for Direct Antivirals Scheduled for May 25, 2023

Date: May 4, 2023 Attention: All Providers Effective Date: May 25, 2023 Call to action: Texas Children’s Health Plan (TCHP) would like to let providers know that effective May 25, 2023, the Health and Human Services Commission (HHSC) is implementing new policies to improve access and adherence to direct antivirals. Providers will now be able to write prescriptions for the entire course of therapy for the direct antivirals, eliminating the need for additional refills. How this impacts providers: Starting May 25, 2023, due to...

By Facilities, OB/GYNs, Office Managers, Primary Care Providers, Provider Alert, Specialists, , , 0 CommentsRead more...
Provider Alert!
02May

Provider Alert! Provider Enrollment Revalidation Extensions to End on May 11, 2023

Date: May 2, 2023 Attention: All Providers Call to action: Texas Children’s Health Plan would like to remind providers that effective May 11, 2023, the Health and Human Services Commission (HHSC) will end the flexibility of extended Medicaid provider revalidation dates that came due during the COVID-19 public health emergency (PHE). Additional information: Per federal guidance, providers that were due for revalidation effective March 1, 2020, through May 11, 2023, will receive a post-PHPHE grace period to complete the revalidation process. Texas Medicaid and...

By Facilities, OB/GYNs, Office Managers, Primary Care Providers, Provider Alert, Specialists, , , , 0 CommentsRead more...
Provider Alert!
28Apr

Provider Alert! Non-Formulary Requests for Obesity Control Drugs

Date: April 28, 2023 Attention: All Providers Effective Date: March 1, 2023 Call to action: Texas Children’s Health Plan (TCHP) would like to let providers know that effective March 1, 2023, the Health and Human Services Commission (HHSC) will no longer approve medically necessary non-formulary drug requests for obesity control drugs for individuals 21 years and older. This aligns with the Social Security Act, Section 1905, since coverage of these drugs is not included in the Medicaid State Plan. The drugs excluded from...

By Facilities, OB/GYNs, Office Managers, Primary Care Providers, Provider Alert, Specialists, , , 0 CommentsRead more...
Provider Alert!
28Apr

Provider Alert! New Audit Programs Vendor EXL

Date: April 27, 2023 Attention: All Providers Effective Date: April 26, 2023 Call to action: Texas Children’s Health Plan (TCHP) Controls and Compliance (CC) would like to let providers know that TCHP has contracted with an external auditor, ExlService.com (EXL) to support its upcoming audit efforts. For your awareness, TCHP’s CC is organized within the Office of General Counsel under the Controls and Compliance Department. EXL is currently conducting audits, and will introduce the following new audit programs starting April 26, 2023: High Cost Drug...

By Facilities, OB/GYNs, Office Managers, Primary Care Providers, Provider Alert, Specialists, , , , 0 CommentsRead more...
Provider Alert!
27Apr

Provider Alert! UPDATE: Provider Enrollment and Management System (PEMS) Provider Guidance

Date: April 27, 2023 Attention: All Providers NEW Effective Date: June 30, 2023 Important provider notice: As a reminder, the Provider Enrollment and Management System (PEMS) is the required Texas Medicaid & Healthcare Partnership (TMHP) program which is the single tool for provider enrollment, reenrollment, revalidation, and maintenance requests (maintaining and updating provider enrollment record information) for Texas Medicaid. Accordingly, as an MCO, TCHP will contract, credential and pay only those providers who are properly enrolled with TMHP and whose information is received in...

By Facilities, OB/GYNs, Office Managers, Primary Care Providers, Provider Alert, Specialists, , , , 0 CommentsRead more...
Provider Alert!
25Apr

Provider Alert! Clinical Criteria Revision for Cibinqo Effective May 31, 2023

Date: April 25, 2023 Attention: All Providers Effective Date: May 31, 2023 Call to action: Texas Children’s Health Plan (TCHP) would like to inform providers that effective May 31, 2023, the Health and Human Services Commission (HHSC) will expand coverage for Cibinqo to adolescents 12-18 years of age due to a recent U.S. Food and Drug Administration (FDA) approval. Cibinqo belongs to a class of medications called Janus Kinase (JAK) Inhibitors and is indicated for the treatment of adults with refractory moderate-to-severe atopic...

By Facilities, OB/GYNs, Office Managers, Primary Care Providers, Provider Alert, Specialists, , , 0 CommentsRead more...
Provider Alert!
25Apr

Provider Alert! Olumiant Clinical Prior Authorization Revision Effective March 27

Date: April 21, 2023 Attention: All Providers Effective Date: March 27, 2023 Call to action: Texas Children’s Health Plan (TCHP) would like to inform providers that effective March 27, 2023, the Health and Human Services Commission (HHSC) revised the clinical prior authorization approval criteria for Olumiant, a Janus Kinase (JAK) Inhibitor. Olumiant is prescribed for adults with severe alopecia areata and adults with moderate to severely active rheumatoid arthritis. The prior authorization approval criteria revisions were made to match the information in the...

By Facilities, OB/GYNs, Office Managers, Primary Care Providers, Provider Alert, Specialists, , , 0 CommentsRead more...
Provider Alert!
25Apr

Provider Alert! Lidocaine 5% Patch Added To PDL

Date: April 21, 2023 Attention: All Providers Effective Date: April 3, 2023 Call to action: Texas Children’s Health Plan (TCHP) would like to inform providers that effective April 3, 2023, the Texas Health and Human Services Commission (HHSC) temporarily removed the non-preferred status from the generic product, Lidocaine 5% patches on the preferred drug list (PDL). The preferred status of the brand name products (NDC 63481-0687-06) will not change to allow for any existing stock available to be utilized. This is in response...

By Facilities, OB/GYNs, Office Managers, Primary Care Providers, Provider Alert, Specialists, , , 0 CommentsRead more...
Provider Alert!
20Apr

Provider Alert! Provider Offices are eligible for Incentive with Completion of Provider Satisfaction Survey

Date: April 19, 2023 Attention: All Providers Launch timeframe: Spring 2023 Call to action: Texas Children’s Health Plan (TCHP) is excited to launch our annual Provider Satisfaction Survey this spring- this time with a new feature. Provider offices that complete the survey will be entered into a gift card drawing*. Winning practices will be contacted at the conclusion of the survey. SPH Analytics will be facilitating the survey during this spring. This way, the individual survey responses remain anonymous. When the time comes, you...

By Facilities, OB/GYNs, Office Managers, Primary Care Providers, Provider Alert, Specialists0 CommentsRead more...